EUVIMEDEUVIMED entdecken
Crossref

TUG1 exacerbates cerebral ischemia-reperfusion injury through miR-340-5p-mediated PTEN

Fei Li, Hui-Kai Zhang, Hong-Xiang Jiang, Xin-Yuan Zhang, Qian-Xue Chen

Journal of Molecular Histology · 2024

DOI: 10.1007/s10735-024-10224-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Histology, 2024. Verfasst von Fei Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China. Hauptthemen laut MEDLINE: PTEN Phosphohydrolase, MicroRNAs, RNA, Long Noncoding, Reperfusion Injury. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long non-coding RNAs (LncRNAs) play a substantial role in the process of cerebral ischemia-reperfusion injury (CIRI). The present work aimed to determine the probable mechanism by which LncRNA TUG1 exacerbates CIRI via the miR-340-5p/phosphatase and tensin homolog (PTEN) pathway. After developing a middle cerebral artery occlusion/reperfusion (MCAO/R) model, pcDNA-TUG1 together with miR-340-5p agomir were administrated in vivo. Furthermore, the neurologic defects in rats were assessed by a modified neurological severity score. Moreover, 2,3,5-Triphenyl-2 H-tetrazolium chloride stain-step was performed to determine the brain's infarct size. In addition, western blotting, immunohistochemistry, and qRT-PCR experiments were utilized for gauging the proteomic/genomic expression-profiles. Luciferase reporter assay validated correlations across TUG1, miR-340-5p, together with PTEN. The results indicated relatively reduced miR-340-5p levels in MCAO/R models, while upregulated TUG1 levels. The pcDNA-TUG1-treated rats indicated increasing neurological dysfunction, whereas the miR-340-5p agomir-treated rats showed improvement. Furthermore, miR-340-5p was determined to be the expected and confirmed TUG1 target. All things considered, the findings suggested that PTEN can serve as the target of miR-340-5p. In addition, TUG1 served as a miR-340-5p ceRNA, which promotes PTEN modulation. Furthermore, TUG1 overexpression decreased miR-340-5p's capacity to fend against CIRI. Conclusively, this work proved that in CIRI, targeting the TUG1/miR-340-5p/PTEN regulatory axis is a viable approach for the treatment of ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PTEN PhosphohydrolaseMicroRNAsRNA, Long NoncodingReperfusion InjuryAnimalsRatsMaleRats, Sprague-DawleyDisease Models, AnimalInfarction, Middle Cerebral ArteryBrain IschemiaGene Expression Regulation

Stichwörter der Autor:innen

Cerebral ischemia-reperfusion injuryIschemic strokePhosphatase and tensin homologTaurine-upregulated gene 1miR-340-5p

Substanzen

PTEN PhosphohydrolaseMicroRNAsRNA, Long NoncodingTUG1 long noncoding RNA, ratMIRN340-1 microRNA, ratPten protein, rat

Autor:innen und Institutionen

  • Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, 430060, China. chenqx666@sohu.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, F., Zhang, H. K., Jiang, H. X., Zhang, X. Y., & Chen, Q. X. (2024). TUG1 exacerbates cerebral ischemia-reperfusion injury through miR-340-5p-mediated PTEN. Journal of Molecular Histology. https://doi.org/10.1007/s10735-024-10224-2

Vancouver

Li F, Zhang HK, Jiang HX, Zhang XY, Chen QX. TUG1 exacerbates cerebral ischemia-reperfusion injury through miR-340-5p-mediated PTEN. Journal of Molecular Histology. 2024. doi:10.1007/s10735-024-10224-2

BibTeX
@article{Li2024,
  author = {Li, Fei and Zhang, Hui-Kai and Jiang, Hong-Xiang and Zhang, Xin-Yuan and Chen, Qian-Xue},
  title = {TUG1 exacerbates cerebral ischemia-reperfusion injury through miR-340-5p-mediated PTEN},
  journal = {Journal of Molecular Histology},
  year = {2024},
  doi = {10.1007/s10735-024-10224-2}
}
Kostenlos starten →